Prestige Consumer Healthcare Inc. Buyback
OLI recorded this information on 3/2/2020
Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that the Company's Board of Directors authorized the repurchase of up to $25.0 million of the Company's issued and outstanding common stock. Separately, the Company plans to present at the Raymond James Institutional Investors Conference at 8:40 a.m. ET today, March 2nd.
Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, marketing, sales, and distribution of over-the-counter (OTC) health and personal care products. Co. conducts its operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare. Co.'s brands in the North American OTC Healthcare segment include Boudreaux's Butt Paste baby ointments with products that include various diaper rash treatments and skin protectants. Co.'s brands in the International OTC Healthcare segment include Fess nasal saline sprays and washes.
PBH SEC Filing Email Alerts Service
Open the PBH Page at The Online Investor »
Open the PBH Page at The Online Investor (in a new window) »
Free PBH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Buy (3.33 out of 4)
(ranked lower than approx. 54% of all stocks covered)
Analysts' Target Price:
PBH Stock Forecast
Based on Zacks ABR data;
powered by Xignite